Immutep Total Current Liabilities from 2010 to 2025

IMMP Stock  USD 1.86  0.04  2.20%   
Immutep Total Current Liabilities yearly trend continues to be relatively stable with very little volatility. Total Current Liabilities is likely to grow to about 12.7 M this year. Total Current Liabilities is the total amount of liabilities that Immutep Ltd ADR is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. View All Fundamentals
 
Total Current Liabilities  
First Reported
2011-06-30
Previous Quarter
10.5 M
Current Value
9.2 M
Quarterly Volatility
2.7 M
 
Yuan Drop
 
Covid
Check Immutep financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immutep's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 26.2 K or Selling General Administrative of 9.3 M, as well as many indicators such as Price To Sales Ratio of 80.26, Dividend Yield of 0.0 or PTB Ratio of 2.06. Immutep financial statements analysis is a perfect complement when working with Immutep Valuation or Volatility modules.
  
Check out the analysis of Immutep Correlation against competitors.

Latest Immutep's Total Current Liabilities Growth Pattern

Below is the plot of the Total Current Liabilities of Immutep Ltd ADR over the last few years. Total Current Liabilities is an item on Immutep balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Immutep Ltd ADR are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Immutep's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immutep's overall financial position and show how it may be relating to other accounts over time.
Total Current Liabilities10 Years Trend
Slightly volatile
   Total Current Liabilities   
       Timeline  

Immutep Total Current Liabilities Regression Statistics

Arithmetic Mean5,543,631
Geometric Mean4,045,381
Coefficient Of Variation67.79
Mean Deviation2,959,546
Median4,444,472
Standard Deviation3,757,940
Sample Variance14.1T
Range12.5M
R-Value0.86
Mean Square Error3.9T
R-Squared0.74
Significance0.000018
Slope680,199
Total Sum of Squares211.8T

Immutep Total Current Liabilities History

202512.7 M
202412.1 M
202310.5 M
20229.8 M
20216.4 M
20205.3 M
20193.4 M

About Immutep Financial Statements

Immutep shareholders use historical fundamental indicators, such as Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Immutep investors may analyze each financial statement separately, they are all interrelated. The changes in Immutep's assets and liabilities, for example, are also reflected in the revenues and expenses on on Immutep's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Current Liabilities12.1 M12.7 M

Additional Tools for Immutep Stock Analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.